Superior Genomics is a developer of technologies advancing medicine, diagnostics, and personalized healthcare through advanced sequencing.
Superior Genomics has raised $508K in total funding. The most recent round was Seed. The last funding was announced in August 2026.
Superior Genomics is headquartered in Norway, United States.
Superior Genomics is a developer of technologies advancing medicine, diagnostics, and personalized healthcare through advanced sequencing.
Superior Genomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Superior Genomics — Funding & Investors." VCBacked, August 14, 2026, https://www.vcbacked.co/company/superior-genomics. Accessed September 2, 2026.
VCBacked. (2026). Superior Genomics — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/superior-genomics
{{cite web |title=Superior Genomics — Funding & Investors |url=https://www.vcbacked.co/company/superior-genomics |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated